Abbott, Myriad to work jointly on drug development

04/12/2006 | Chicago Tribune (tiered subscription model)

Abbott Laboratories and Myriad Genetics are joining forces to allow the drugmaker to draw on Myriad's genetics and other drug-discovery technologies to produce novel products. Under the pact, Myriad will work to identify the genetic bases of diseases so Abbott can identify targets for drugs it might want to develop.

View Full Article in:

Chicago Tribune (tiered subscription model)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Vice President, Idaho Regional Director
Boise, ID